🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study evaluates the efficacy and safety of ombitasvir/paritaprevir/rit...
Status
Completed
Location
Multiple Locations
Start Date
2015-09-30
Trial ID
NCT02487199
Treatments Being Tested
Patients with newly diagnosed CML have excellent outcomes with tyrosine kin...
Status
Completed
Location
Helsinki University Central Hospital
Start Date
2012-09
Trial ID
NCT01725204
Treatments Being Tested
All enrolled patients must meet the European Guidelines for the Prevention ...
Status
Not Yet Recruiting
Location
Huashan Hospital, Fudan University
Start Date
2025-04-01
Trial ID
NCT06900166
Treatments Being Tested
This study is intended to evaluate if 12 or 24 weeks of treatment with GSK3...
Status
Completed
Location
GSK Investigational Site
Start Date
2021-01-28
Trial ID
NCT04676724
Treatments Being Tested
The purpose of this trial is to assess the effect of switching CML patients...
Status
Terminated
Location
Aarhus University Hospital
Start Date
2013-04
Trial ID
NCT01866553
Treatments Being Tested
This is a prospective, multicentre observational follow-up study of PegIFN ...
Status
Unknown
Location
BeiJing YouAn Hospital, Capital Medical University
Start Date
2018-02-27
Trial ID
NCT03358108
The objective was to investigate the antiviral effect, safety, and pharmaco...
Status
Completed
Location
1220.5.0001 Boehringer Ingelheim Investigational Site
Start Date
2008-10
Trial ID
NCT00774397
As HBsAg clearance is uncommon in chronic hepatitis B (CHB) patients on nuc...
Status
Unknown
Location
The third affiliated hospital of Sun Yat-sen University
Start Date
2016-04
Trial ID
NCT02745704
Treatments Being Tested
The objective of this trial is to investigate tolerability, safety, pharmac...
Status
Completed
Location
1241.25.002 Boehringer Ingelheim Investigational Site
Start Date
2012-02
Trial ID
NCT01528735
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of TMC435 ...
Status
Completed
Location
Multiple Locations
Start Date
2011-01
Trial ID
NCT01290731
Treatments Being Tested